Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Functional AdoMet Isosteres Resistant to Classical AdoMet Degradation Pathways

  • Tyler D. Huber
  • , Fengbin Wang
  • , Shanteri Singh
  • , Brooke R. Johnson
  • , Jianjun Zhang
  • , Manjula Sunkara
  • , Steven G. Van Lanen
  • , Andrew J. Morris
  • , George N. Phillips
  • , Jon S. Thorson

Producción científica: Articlerevisión exhaustiva

47 Citas (Scopus)

Resumen

S-adenosyl-l-methionine (AdoMet) is an essential enzyme cosubstrate in fundamental biology with an expanding range of biocatalytic and therapeutic applications. We report the design, synthesis, and evaluation of stable, functional AdoMet isosteres that are resistant to the primary contributors to AdoMet degradation (depurination, intramolecular cyclization, and sulfonium epimerization). Corresponding biochemical and structural studies demonstrate the AdoMet surrogates to serve as competent enzyme cosubstrates and to bind a prototypical class I model methyltransferase (DnrK) in a manner nearly identical to AdoMet. Given this conservation in function and molecular recognition, the isosteres presented are anticipated to serve as useful surrogates in other AdoMet-dependent processes and may also be resistant to, and/or potentially even inhibit, other therapeutically relevant AdoMet-dependent metabolic transformations (such as the validated drug target AdoMet decarboxylase). This work also highlights the ability of the prototypical class I model methyltransferase DnrK to accept non-native surrogate acceptors as an enabling feature of a new high-throughput methyltransferase assay.

Idioma originalEnglish
Páginas (desde-hasta)2484-2491
Número de páginas8
PublicaciónACS Chemical Biology
Volumen11
N.º9
DOI
EstadoPublished - sept 16 2016

Nota bibliográfica

Publisher Copyright:
© 2016 American Chemical Society.

Financiación

This work was supported in part by the National Institutes of Health Protein Structure Initiative (U01 GM098248, G.N.P.,J.), National Institutes of Health R37 AI52188 (J.S.T.), National Institutes of Health GM109456 (G.N.P.,J.), the National Center f o r Advancing Translational Sciences (UL1TR000117), and the University of Kentucky College of Pharmacy and Markey Cancer Center. We also thank the University of Kentucky Mass Spectrometry Facility (ASTeCC) for HRMS support; the staff at the LS-CAT, SBC-CAT, and GM/CA beamline at the Advanced Photo Source for help in conducting trial attempts and collecting the diffraction data; and K. A. Shaaban (University of Kentucky Center for Pharmaceutical Research and Innovation) for consultation.

FinanciadoresNúmero del financiador
National Institutes of Health Protein Structure InitiativeU01 GM098248
Center for Pharmaceutical Research and Innovation, University of Kentucky
University of Kentucky College of Pharmacy
University of Kentucky Mass Spectrometry Facility
National Institutes of Health (NIH)R37 AI52188
National Institute of General Medical Sciences DP2GM119177 Sophie Dumont National Institute of General Medical SciencesR01GM109456
National Center for Advancing Translational Sciences (NCATS)UL1TR000117
University of Kentucky Markey Comprehensive Cancer Center

    ASJC Scopus subject areas

    • Biochemistry
    • Molecular Medicine

    Huella

    Profundice en los temas de investigación de 'Functional AdoMet Isosteres Resistant to Classical AdoMet Degradation Pathways'. En conjunto forman una huella única.

    Citar esto